TY - JOUR A1 - Zimniak, Melissa A1 - Kirschner, Luisa A1 - Hilpert, Helen A1 - Geiger, Nina A1 - Danov, Olga A1 - Oberwinkler, Heike A1 - Steinke, Maria A1 - Sewald, Katherina A1 - Seibel, Jürgen A1 - Bodem, Jochen T1 - The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue JF - Scientific Reports N2 - To circumvent time-consuming clinical trials, testing whether existing drugs are effective inhibitors of SARS-CoV-2, has led to the discovery of Remdesivir. We decided to follow this path and screened approved medications "off-label" against SARS-CoV-2. Fluoxetine inhibited SARS-CoV-2 at a concentration of 0.8 mu g/ml significantly in these screenings, and the EC50 was determined with 387 ng/ml. Furthermore, Fluoxetine reduced viral infectivity in precision-cut human lung slices showing its activity in relevant human tissue targeted in severe infections. Fluoxetine treatment resulted in a decrease in viral protein expression. Fluoxetine is a racemate consisting of both stereoisomers, while the S-form is the dominant serotonin reuptake inhibitor. We found that both isomers show similar activity on the virus, indicating that the R-form might specifically be used for SARS-CoV-2 treatment. Fluoxetine inhibited neither Rabies virus, human respiratory syncytial virus replication nor the Human Herpesvirus 8 or Herpes simplex virus type 1 gene expression, indicating that it acts virus-specific. Moreover, since it is known that Fluoxetine inhibits cytokine release, we see the role of Fluoxetine in the treatment of SARS-CoV-2 infected patients of risk groups. KW - SARS-CoV-2 KW - viral epidemiology KW - viral infection Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-259820 VL - 11 ER - TY - THES A1 - Zhang, Guoliang T1 - Phytochemical Research on Two Ancistrocladus Species, Semi-Synthesis of Dimeric Naphthylisoquinoline Alkaloids, and Structure Optimization of Antitumoral Naphthoquinones T1 - Phytochemische Untersuchungen an zwei Ancistrocladus-Arten, Semi-Synthese dimerer Naphthylisochinolin-Alkaloide und Strukturoptimierung von antitumoralen Naphthochinonen N2 - Plant-derived natural products and their analogs continue to play an important role in the discovery of new drugs for the treatment of human diseases. Potentially promising representatives of secondary metabolites are the naphthylisoquinoline alkaloids, which show a broad range of activities against protozoan pathogens, such as plasmodia, leishmania, and trypanosoma. Due to the increasing resistance of those pathogens against current therapies, highly potent novel agents are still urgently needed. Thus, it is worthy to discover new naphthylisoquinoline alkaloids hopefully with pronounced bioactivities by isolation from plants or by synthesis. The naphthylisoquinoline alkaloids are biosynthetically related to another class of plant-derived products, the naphthoquinones, some of which have been recently found to display excellent anti-multiple myeloma activities without showing any cytotoxicities on normal blood cells. Multiple myeloma still remains incurable, although remissions may be induced with co-opted therapeutic treatments. Therefore, more potent naphthoquinones are urgently required, and can be obtained by isolation from plants or by synthesis. In detail, the results in this thesis are listed as follows: 1) Isolation and characterization of naphthylisoquinoline alkaloids from the stems of a Chinese Ancistrocladus tectorius species. Nine new naphthylisoquinoline alkaloids, named ancistectorine A1 (60), N-methylancistectorine A1 (61), ancistectorine A2 (62a), 5-epi-ancistectorine A2 (62b), 4'-O-demethylancistectorine A2 (63), ancistectorine A3 (64), ancistectorine B1 (65), ancistectorine C1 (66), and 5-epi-ancistrolikokine D (67) were isolated from the Chinese A. tectorius and fully characterized by chemical, spectroscopic, and chiroptical methods. Furthermore, the in vitro anti-infectious activities of 60-62 and 63-66 have been tested. Three of the metabolites, 61, 62a, and 62b, exhibited strong antiplasmodial activities against the strain K1 of P. falciparum without showing significant cytotoxicities. With IC50 values of 0.08, 0.07, and 0.03 μM, respectively, they were 37 times more active than the standard chloroquine (IC50 = 0.26 μM). Moreover, these three compounds displayed high antiplasmodial selectivity indexes ranging from 100 to 3300. According to the TDR/WHO guidelines, they could be considered as lead compounds. In addition, seven alkaloids, 69-74 (structures not shown here), were isolated from A. tectorius that were known, but new to the plant, together with another fourteen known compounds (of these, only the structures of the three main alkaloids, 5a, 5b, and 78 are shown here), which had been previously found in the plant. The three metabolites ancistrocladine (5a), hamatine (5b), and (+)-ancistrocline (78) were found to show no or moderate activities against the MM cell lines. 2) Isolation and characterization of naphthylisoquinoline alkaloids from the root bark of a new, botanically yet undescribed Congolese Ancistrocladus species. An unprecedented dimeric Dioncophyllaceae-type naphthylisoquinoline alkaloid, jozimine A2 (84), as first recognized by G. Bauckmann from an as yet undescribed Ancistrocladus species, was purified and characterized as part of this thesis. Its full structural assignment was achieved by spectroscopic and chiroptical methods, and further confirmed by an X-ray diffraction analysis, which had never succeeded for any other dimeric naphthylisoquinoline alkaloids before. Structurally, the dimer is composed of two identical 4'-O-demethyldioncophylline A halves, coupled through a sterically hindered central axis at C-3',3'' of the two naphthalene moieties. Pharmacologically, jozimine A2 (84) showed an extraordinary antiplasmodial activity (IC50 = 1.4 nM) against the strain NF54 of P. falciparum. Beside jozimine A2 (85), another new alkaloid, 6-O-demethylancistrobrevine C (84), and four known ones, ancistrocladine (5a), hamatine (5b), ancistrobrevine C (86), and dioncophylline A (6) were isolated from the Ancistrocladus species, the latter in a large quantity (~500 mg), showing that the plant produces Ancistrocladaceae-type, mixed-Ancistrocladaceae/Dioncophyllaceae-type, and Dioncophyllaceae-type naphthyl- isoquinoline alkaloids. Remarkably, it is one of the very few plants, like A. abbreviatus, and A. barteri, that simultaneously contain typical representatives of all the above three classes of alkaloids. 3) Semi-synthesis of jozimine A2 (85), 3'-epi-85, jozimine A3 (93) and other alkaloids from dioncophylline A (6). The dimeric naphthylisoquinoline alkaloids, jozimine A2 (85) and 3'-epi-85, constitute rewarding synthetic targets for a comparative analysis of their antiplasmodial activities and for a further confirmation of the assigned absolute configurations of the isolated natural product of 85. They were semi-synthesized in a four-step reaction sequence from dioncophylline A (6) in cooperation with T. Büttner. The key step was a biomimetic phenol-oxidative dimerization at C-3' of the N,O-dibenzylated derivative of 89 by utilizing Pb(OAc)4. This is the first time that the synthesis of such an extremely sterically hindered (four ortho-substituents) naphthylisoquinoline alkaloid – with three consecutive biaryl axes! – has been successfully achieved. A novel dimeric naphthylisoquinoline, jozimine A3 (93), bearing a 6',6''-central biaryl axis, was semi-synthesized from 5'-O-demethyldioncophylline A (90) by a similar biomimetic phenol-oxidative coupling reaction as a key step, by employing Ag2O. HPLC analysis with synthetic reference material of 3'-epi-85 and 93 for co-elution revealed that these two alkaloids clearly are not present in the crude extract of the Ancistrocladus species from which jozimine A2 (85) was isolated. This evidences that jozimine A2 (85) is very specifically biosynthesized by the plant with a high regio- and stereoslectivity. Remarkably, the two synthetic novel dimeric naphthylisoquinoline alkaloids 3'-epi-85 and 93 were found to display very good antiplasmodial activities, albeit weaker than that of the natural and semi-synthetic product 85. Additionally, the two compounds 3'-epi-85 and 93 possessed high or moderate selectivity indexes, which were much lower than that of 85. However, they can still be considered as new lead structures. Two unprecedented oxidative products of dioncophylline A, the diastereomeric dioncotetralones A (94a) and B (94b), were synthesized from dioncophylline A (6) in a one-step reaction. Remarkably, the aromatic properties in the “naphthalene” and the “isoquinoline” rings of 94a and 94b are partially lost and the “biaryl” axis has become a C,C-double bond, so that the two halves are nearly co-planar to each other, which has never been found among any natural or synthetic naphthylisoquinoline alkaloid. Their full structural characterization was accomplished by spectroscopic methods and quantum-chemical CD calculations (done by Y. Hemberger). The presumed reaction mechanism was proposed in this thesis. In addition, one of the two compounds, 94a, exhibited a highly antiplasmodial activity (IC50 = 0.09 μM) with low cytotoxicity, and thus, can be considered as a new promising lead structure. Its 2'-epi-isomer, 94b, was inactive, evidencing a significant effect of chirality on the bioactivity. Of a number of naphthylisoquinoline alkaloids tested against the multiple-myeloma cell lines, the three compounds, dioncophylline A (6), 4'-O-demethyldioncophylline A (89), and 5'-O-demethyldioncophylline A (90) showed excellent activities, even much stronger than dioncoquinones B (10), C (102), the epoxide 175, or the standard drug melphalan. 4) Isolation and characterization of bioactive naphthoquinones from cell cultures of Triphyophyllum peltatum. Three new naphthoquinones, dioncoquinones C (102), D (103), and E (104), the known 8-hydroxydroserone (105), which is new to this plant, and one new naphthol dimer, triphoquinol A (107), were isolated from cell cultures of T. peltatum in cooperation with A. Irmer. Dioncoquinone C (102) showed an excellent activity against the MM cells, very similar to that of the previously found dioncoquinone B (10), without showing any inhibitory effect on normal cells. The other three naphthoquinones, 103105, were inactive or only weakly active. 5) Establishment of a new strategy for a synthetic access to dioncoquinones B (10) and C (102) on a large scale for in vivo experiments and for the synthesis of their analogs for first SAR studies. Before the synthesis of dioncoquinone B (10) described in this thesis, two synthetic pathways had previously been established in our group. The third approach described here involved the preparation of the joint synthetic intermediate 42 with the previous two routes. The tertiary benzamide 135 was ortho-deprotonated by using s-BuLi/TMEDA, followed by transmetallation with MgBr2▪2Et2O, and reaction with 2-methylallyl bromide (139). It resulted in the formation of ortho-allyl benzamide 140, which was cyclized by using methyl lithium to afford the naphthol 42. This strategy proved to be the best among the established three approaches with regard to its very low number of steps and high yields. By starting with 136, this third strategy yielded the related bioactive natural product, dioncoquinone C (102), which was accessed by total synthesis for the first time. To identify the pharmacophore of the antitumoral naphthoquinones, a library of dioncoquinone B (10) and C (102) analogs were synthesized for in vitro testing. Among the numerous naphthoquinones tested, the synthetic 7-O-demethyldioncoquinone C (or 7-O-hydroxyldioncoquinone B) (145), constitutes another promising basic structure to develop a new anti-MM agent. Furthermore, preliminary SAR results evidence that the three hydroxy functions at C-3, C-5, and C-6 are essential for the biological properties as exemplarily shown through the compounds 10, 102, and 145. All other mixed OH/OMe- or completely OMe-substituted structures were entirely inactive. By a serendipity the expoxide 175 was found to display the best anti-MM activity of all the tested isolated metabolites from T. peltatum, the synthesized naphthoquinones, and their synthetic intermediates. Toxic effects of 175 on normal cells were not observed, in contrast to the high toxicities of all other epoxides. Thus, the anti-MM activity of 175 is of high selectivity. The preliminary SAR studies revealed that the 6-OMe group in 175 is required, thus differed with the above described naphthoquinones (where 6-OH is a requisite in 10, 102, and 145), which evidenced potentially different modes of action for these two classes of compounds. 6) The first attempted total synthesis of the new naturally occurring triphoquinone (187a), which was recently isolated from the root cultures of T. peltatum in our group. A novel naphthoquinone-naphthalene dimer, 187a (structure shown in Chapter 10), was isolated in small quantities from the root cultures of T. peltatum. Thus, its total synthesis was attempted for obtaining sufficient amounts for selected biotestings. The key step was planned to prepare the extremely sterically hindered (four ortho-substituents) binaphthalene 188 by a coupling reaction between the two 2-methylnaphthalene derivatives. Test reactions involving a system of two simplified 2-methylnaphthylboron species and 2-methylnaphthyl bromide proved the Buchwald ligand as most promising. The optimized conditions were then applied to the two true - highly oxygenated - coupling substrates, between the 2-methylnaphthylboron derivatives 210, 211, 213, or 214 and the 2-methylnaphthyl iodides (or bromides) 215 (206), 215 (206), 212 (205), or 212 (205), respectively. Unfortunately, this crucial step failed although various bases and solvent systems were tested. This could be due to the high electron density of the two coupling substrates, both bearing strongly OMOM/OMe-donating function groups. Therefore, a more powerful catalyst system or an alternative synthetic strategy must be explored for the total synthesis of 187a. 7) Phytochemical investigation of the Streptomyces strain RV-15 derived from a marine sponge. Cyclodysidins A-D (216-219), four new cyclic lipopeptides with a- and ß-amino acids, were isolated from the Streptomyces strain RV15 derived from a marine sponge by Dr. U. Abdelmohsen. Their structures were established as cyclo-(ß-AFA-Ser-Gln-Asn-Tyr-Asn-Ser-Thr) by spectroscopic analysis using 2D NMR techniques and CID-MS/MS in the course of this thesis. In conclusion, the present work contributes to the discovery of novel antiplasmodial naphthylisoquinoline alkaloids and antitumoral naphthoquinones, which will pave the way for future studies on these two classes of compounds. N2 - Naturstoffe pflanzlichen Ursprungs und deren Derivate waren seit jeher eine wichtige Quelle für die Entdeckung neuer Arzneistoffe. Darunter stellen die Naphthylisochinolin-Alkaloide eine besonders bedeutsame Klasse an Sekundärmetaboliten dar, die gegen eine breite Vielfalt an pathogenen Protozoen, wie z.B. Plasmodien, Leishmanien und Trypanosomen, aktiv sind. Die zunehmende Resistenz dieser Krankheitserreger gegen vorhandene Therapeutika macht die Erschließung neuer hochwirksamer Substanzen – durch direkte Isolierung aus Pflanzenmaterial oder chemische Synthese – zu einer lohnenswerten Aufgabe. Kürzlich wurde entdeckt, dass Naphthochinone, eine biosynthetisch eng mit den Naphthylisochinolin-Alkaloiden verwandte Naturstoffklasse, exzellente Aktivitäten gegen das Multiple Myelom aufweist. Diese Krebserkrankung ist mit gegenwärtigen Arzneimitteln nicht heilbar, wenngleich unterstützende Therapeutika zu einer Remission führen können. Die Suche nach pharmakologisch wirksamen Naphthochinonen, mittels Isolierung aus Pflanzen oder durch chemische Synthese, ist daher dringend geboten. Die Ergebnisse dieser Arbeit umfassen im Detail die folgenden Teilbereiche: 1) Isolierung diverser Naphthylisochinolin-Alkaloide aus dem Stamm der chinesischen Ancistrocladus tectorius Spezies. Es Wurch neun neue Naphthylisochinlin-Alkaloide aus der in China beheimateten Pflanze A. tectorius. Diese umfassten die sechs 5,1'-gekuppelten Verbindungen Ancistectorin A1 (60), N-Methylancistectorin A1 (61), Ancistectorin A2 (62a), 5-epi-Ancistectorin A2 (62b), 4'-O-Demethylancistectorin A2 (63), Ancistectorin A3 (64), das 7,1'-gekuppelte Ancistectorin B1 (65), das 7,8'-verknüpfte Ancistectorin C1 (66), sowie das 5,8'-verknüpfte 5-epi-Ancistrolikokin D (65) die allesamt vollständig charakterisiert und auf ihre antiplasmodiale Aktivität untersucht wurden. Drei dieser Metabolite, 61, 62a, und 62b, zeigten eine starke antiplasmodiale Aktivität gegen den Stamm K1 von P. falciparum und dennoch keine signifikante Cytotoxizität. Mit IC50-Werten von 0.08, 0.07 und 0.03 μM waren sie 37 mal aktiver als der Standard Chloroquin (IC50 = 0.26 μM). Darüber hinaus verfügten diese drei Verbindungen über einen hohen antiplasmodialen Index von 100 bis 300. Laut WHO-Richtlinien können diese erfolgversprechenden Antimalaria-Wirkstoffe als neue Leitstrukturen angesehen werden. Des Weiteren wurden sieben bekannte Alkaloide, 69-74 (nicht abgebildet), erstmals aus A. tectorius isoliert. 14 weitere, aus dieser Pflanze bereits bekannte, Verbindungen (z.B. 5a, 5b, und 78) wurden ebenfalls gefunden. Die drei Hauptalkaloide Ancistrocladin (5a), Hamatin (5b) und (+)-Ancistroclin (78) hatten jedoch keine bzw. nur mäßige Aktivitäten gegen MM-Zelllinien. 2) Isolierung der Naphthylisochinolin-Alkaloide aus der Stammrinde einer neuen und botanisch noch unbeschriebenen, kongolesichen Ancistrocladus Spezies. Ein beispielloses dimeres Naphthylisochinolin-Alkaloid aus der Klasse der Dioncophyllaceae, Jozimin A2 (85), wurde aus einer bis dahin noch nicht beschriebenen Ancistrocladus Spezies in Zusammenarbeit mit G. Bauckmann isoliert. Mithilfe von spektroskopischen und chiroptischen Methoden erfolgte die vollständige Strukturaufklärung. Zum ersten Mal bei einem dimeren Naphthylisochinolin-Alkaloid wurde darüber hinaus dessen Struktur mittels Röntgenstrukturanalyse verifiziert. Die Struktur weist zwei identische miteinander verknüpfte 4'-O-Demethyldioncophyllin A Hälften auf, die in den Naphthalin-Einheiten an C-3' und C-3'' sterisch so stark gehindert sind, dass eine dritte rotationsstabile – und daher chirale – Achse vorliegt. Jozimin A2 (85) ragt pharmakologisch betrachtet durch die beste bis dahin gemessene antiplasmodiale Aktivität (IC50 = 1.4 nM, P. falciparum NF54) aller natürlichen monomeren und dimeren Naphthylisochinoline heraus. Neben Jozimin A2 (85) wurde ein weiteres neues Alkaloid, 6-O-Demethylancistrobrevin C (84), und die vier bekannten Monomere Ancistrocladin (5a), Hamatin (5b), Dioncophyllin A (6), und Ancistrobrevin C (86) aus dieser Ancistrocladus Spezies isoliert. Man konnte zeigen, dass die Pflanze Naphthylisochinolin-Alkaloide vom Ancistrocladaceae Typ, vom gemischten Ancistrocladaceae/Dioncophyllaceae Typ und vom Dioncophyllaceae Typ produziert. Dies ist umso bemerkenswerter, als dass nur wenige Pflanzen wie A. abbreviatus und A. barteri bekannt sind, die typische Vertreter aller drei Alkaloid-Klassen beinhalten. 3) Semi-Synthese des dimeren Naphthylisochinolin-Alkaloids Jozimine A2 (85) und seiner Derivate. Aufgrund seiner exzellenten antiplasmodialen Aktivität stellte das Naphthylisochinolin-Alkaloid Jozimin A2 (85), eine lohneswerte Zielstruktur für eine Synthese dar. Die Verbindung wurde durch Semisynthese in vier Stufen aus Dioncophyllin A (6) in Zusammenarbeit mit T. Büttner erschlossen. Als Schlüsselschritt erwies sich die biomimetische, oxidative Kupplung von 89 an C-3’ unter Verwendung von Pb(OAc)4. Der Aufbau einer solch sterisch gehinderten, zentralen Achse mit vier ortho-Substituenten wurde zum ersten Mal an Naphthylisochinolin-Alkaloiden erfolgreich durchgeführt. Zusammen mit Jozimin A2 (85) erhielt man sein 3',3''-Atropisomer 3'-epi-85. Parallel dazu wurde Jozimine A3 (93) dargestellt, dessen 6',6''-Zentral-Achse ebenfalls ausgehend von Dioncophyllin A (6) in einer Schlüsselsequenz mittels Ag2O aufgebaut wurde. HPLC-Coelutionsexperimente der synthetisch erhaltenen Verbindungen 3'-epi-85 und 93 zeigten zweifelsfrei, dass die beiden Alkaloide nicht im Rohextrakt der bisher unbestimmten Ancistrocladus-Art, aus welcher Jozimin A2 (85) isoliert wurde, vorhanden waren. Die Biosynthese von 85 erfolgt in der Pflanze offensichtlich mit hoher Spezifität. Die neuen synthetisch hergestellten, dimeren Naphthylisochinolin-Alkaloide 3'-epi-85 und 93 zeigten sehr gute, wenn auch im Vergleich zum natürlichen und semi-synthetisch erhaltenen 85 schwächere, antiplasmodiale Aktivitäten. Desweiteren besitzen die beiden Verbindungen 3'-epi-85 und 93 hohe bzw. moderate Selektivitäts-Indices, welche allerdings weit unter dem Wert von 85 liegen. Nichtsdestotrotz können sie als neue Leitstrukturen betrachtet werden. Im Verlauf der Synthese von Jozimin A2-Derivaten wurden des weiteren die zwei unbekannten Diastereoisomere, Dioncophynon A (94a) and B (94b), synthetisiert. Man erhielt diese in einer Stufe aus Dioncophyllin A (6). Die Strukturen von 94a und 94b zeichneten sich durch einen partiellen Verlust der Aromatizität am Naphthalin-Ring und eine C,C-Doppelbindung an der früheren Biarylachse aus. Die gefundenen Strukturmotive waren bis dahin weder von natürlichen noch von synthetischen Naphthylisochinolinen bekannt. Die vollständige Charakterisierung gelang durch spektroskopische Methoden und quantenchemische CD-Berechnungen (Y. Hemberger). Ein möglicher Mechanismus zur Bildung dieser Moleküle wurde ebenfalls in dieser Arbeit vorgestellt. Darüber hinaus zeigte eine dieser Verbindungen, 94a, eine hohe antiplasmodiale Aktivität (IC50 = 0.09 μM) bei gleichzeitig nur geringer Toxizität und konnte daher als vielversprechende Leitstruktur betrachtet werden. Dagegen war 94b inaktiv, was den signifikanten Effekt stereogener Elemente auf die Bioaktivität unterstrich. Aus einer ganzen Reihe von Naphthylisochinolin-Alkaloiden, die bzgl. ihrer Aktivität gegen das Multiple Myelom getestet wurden, zeigten v.a. drei Verbindungen, nämlich Dioncophyllin A (6), 4'-O-Demethyldioncophyllin A (89) und 5'-O-Demethyldioncophyllin A (90), exzellente Wirksamkeiten und übertrafen dabei sogar die Dioncochinone B (10) und C (102), das Epoxid 175 und die Referenzsubstanz Melphalan. 4) Isolierung der bioaktiven Naphthochinone aus Zellkulturen von Triphyophyllum peltatum. Drei neue Dioncochinone C (102), D (103) und E (104), das für diese Pflanze noch unbekannte 8-Hydroxydroseron (105) und ein neues Naphthalin-Dimer 107 wurden aus Zellkulturen von T. peltatum in Kooperation mit A. Irmer isoliert. Dioncochinon C (102) wies eine ausgezeichnete Aktivität gegen MM-Zellen, ähnlich zu der von Dioncochinon B, auf, wobei jedoch kein inhibierender Effekt auf normale Zellen beobachtet wurde. Die anderen drei Naphthochinone 103105 waren inaktiv oder nur sehr schwach aktiv gegenüber MM-Zellen. 5) Etablierung neuer Strategien für einen Zugang zu den Dioncochinonen B und C im großen Maßstab für In-vivo-Biotests sowie Synthese von Dioncochinon B-Analoga für SAR-Untersuchungen. Vor Beginn dieser Arbeiten zur Synthese von Dioncochinon B (10) existierten bereits zwei, in unserem Arbeitskreis erschlossene, Synthesewege. Die hier beschriebene dritte Möglichkeit zur Darstellung von Dioncochinon B (10) etablierte einen neuen Zugang zu dem gemeinsamen Intermediat 42. Man ortho-deprotonierte zunächst das tertiäre Amid 135 mit sec-BuLiTMEDA, führte anschließend eine Transmetallierung mit MgBr2▪2Et2O durch und setzte das Intermediat mit 2-Methylallylbromid (139) zum ortho-Allylbenzamid 140 um, welches schließlich mit Methyllithium zum Naphthol 42 zyklisiert wurde. Diese Strategie war den beiden früheren Ansätzen hinsichtlich der hohen Ausbeute und der geringen Anzahl an Synthesestufen überlegen. Darauf aufbauend gelang die erste Totalsynthese des bioaktiven Naturstoffes Dioncochinon C (102). Zur Untersuchung der Struktur-Wirkungs-Beziehung und zur Identifizierung des Pharmakophors der antitumoralen Naphthochinone wurden ca. 30 Analoga von Dioncochinon B (10) und C (102) synthetisiert und auf ihre Anti-MM-Wirkung getestet. Unter den zahlreichen dabei untersuchten Derivaten stellte die synthetische Verbindung 7-O-Demethyldioncochinon C (oder 7-O-Hydroxyldioncochinon B) (145) eine weitere vielversprechende Leitstruktur für die Entwicklung neuer Anti-MM-Kandidaten dar. Als besonders bemerkenswert erwiesen sich die antitumoralen Eigenschaften der Verbindungen 10, 102, und 145. Diese besitzen drei Hydroxygruppen an C-3, C-5 und C-6, die für Ihre biologischen Eigenschaften essentiell zu sein scheinen, da alle anderen Strukturen mit einem gemischten OH/OMe-Muster und jene vollständig OMe-substituierten Verbindungen inaktiv waren. Das Expoxid 175, zeigte unter allen natürlich vorkommenden als auch synthetischen Naphthochinonen und deren Derivaten die beste Aktivität gegen das Multiple Myelom. Gleichzeitig wurde keine Toxizität gegenüber normalen Zellen festgestellt. Dies stand im Gegensatz zu anderen Epoxiden, die über recht hohe Toxizitäten verfügten, wenngleich bei sehr guten Anti-MM-Aktivitäten. Umso bemerkenswerter ist die hohe Selektivität von 175 gegenüber Multiple-Myelom-Zellen. Einleitende SAR Studien zu 175 zeigten, dass die O-Me-Gruppe unbedingt erforderlich ist. Dies lässt auf einen von den Naphthochinonen 10, 102 und 145 verschiedenen Wirkmechanismus schließen, da die drei genannten Verbindungen an C-6 eine OH-Funktionalität tragen. 6) Die erste Totalsynthese eines neuen natürlichen Dimers aus T. peltatum, bestehend aus einer Naphthalin- und einer 1,2-Naphthochinon-Einheit. Man isolierte nur in Spuren ein neuartiges Naphthochinon-Naphthalin-Dimer 187a aus Wurzelkulturen von T. peltatum. Die Totalsynthese von 187a sollte deshalb ausreichende Mengen für ausgewählte Biotests verfügbar machen. Den Schlüsselschritt stellte die Kupplung von zwei sterisch sehr stark gehinderten 2-Methylnaphthalin-Ringen mit jeweils zwei ortho-Substituenten dar. Die Kupplung der 2-Methylnaphthylboronsäure -Derivate mit 2-Methylnaphthylbromid führte unter Verwendung des von Buchwald entwickelten Liganden 196, Pd2(dba)3 und geeigneten Lösungsmitteln und Basen zum racemischen Produkt. Die für das oben beschriebene System optimierten Bedingungen wurden auf die beiden genuinen – hoch-oxygenierten – Substrate die 2-Methylnaphthyl boronsäure-Derivate 210, 211, 213, oder 214 und 2-Methylnaphthyliodide (oder -bromide) 215 (206), 215 (206), 212 (205) oder 212 (205) angewandt. Leider führten zahlreiche Versuche unter Erprobung diverser Basen- und Lösungsmittelsysteme nicht zum Erfolg. Eine mögliche Erklärung liegt in der hohen Elektronendichte der beiden Kupplungspartner, die von den zwei bzw. drei Sauerstoffsubstituenten herrührt. Eine alternative Synthesestrategie oder der Einsatz eines leistungsfähigeren Katalysatorsystems muss deshalb zur Totalsynthese von 187a in Erwägung gezogen werden. 7) Phytochemische Untersuchung des marinen Streptomyces-Stammes RV-15 aus Schwämmen. Die vier neuen cyclischen Lipopeptide Cyclodysidin A-D (216219), welche sowohl aus - als auch - Aminosäuren aufgebaut sind, wurden aus RV-15, einem Streptomyces- Stamm, der mit Schwämmen vergesellschaft ist, isoliert. In Zusammenarbeit mit Dr. U. Abdelmohsen identifizierte man deren Struktur als Cyclo-(ß-AFA-Ser-Gln-Asn-Tyr-Asn- Ser-Thr) mithilfe von 2D-NMR-Spektroskopie und CID-MS/MS. KW - Ancistrocladus KW - dimerer Naphthylisochinolin-Alkaloide KW - Naphthochinonen KW - Ancistrocladus KW - Dimeric Naphthylisoquinoline Alkaloids KW - Naphthoquinones Y1 - 2012 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-72734 ER - TY - JOUR A1 - Zhang, Fangyuan A1 - Radacki, Krzysztof A1 - Braunschweig, Holger A1 - Lambert, Christoph A1 - Ravat, Prince T1 - Zinc-[7]helicenocyanine and its discrete π-stacked homochiral Dimer JF - Angewandte Chemie International Edition N2 - In this communication, we demonstrate a novel approach to prepare a discrete dimer of chiral phthalocyanine (Pc) by exploiting the flexible molecular geometry of helicenes, which enables structural interlocking and strong aggregation tendency of Pcs. Synthesized [7]helicene-Pc hybrid molecular structure, zinc-[7]helicenocyanine (Zn-7HPc), exclusively forms a stable dimeric pair consisting of two homochiral molecules. The dimerization constants were estimated to be as high as 8.96×10\(^6\) M\(^{−1}\) and 3.42×107 M\(^{−1}\) in THF and DMSO, respectively, indicating remarkable stability of dimer. In addition, Zn\(^{-7}\)HPc exhibited chiral self-sorting behavior, which resulted in preferential formation of a homochiral dimer also in the racemic sample. Two phthalocyanine subunits in the dimeric form strongly communicate with each other as revealed by a large comproportionation constant and observation of an IV-CT band for the thermodynamically stable mixed-valence state. KW - organic chemistry KW - supramolecular assembly KW - chirality KW - helicenes KW - homochiral dimer KW - phthalocyanines Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-256534 VL - 60 ER - TY - JOUR A1 - Zhang, Fangyuan A1 - Michail, Evripidis A1 - Saal, Fridolin A1 - Krause, Ana-Maria A1 - Ravat, Prince T1 - Stereospecific Synthesis and Photophysical Properties of Propeller-Shaped C\(_{90}\)H\(_{48}\) PAH JF - Chemistry - A European Journal N2 - Herein, we have synthesized an enantiomerically pure propeller‐shaped PAH, C\(_{90}\)H\(_{48}\), possessing three [7]helicene and three [5]helicene subunits. This compound can be obtained in gram quantities in a straightforward manner. The photophysical and chiroptical properties were investigated using UV/Vis absorption and emission, optical rotation and circular dichroism spectroscopy, supported by DFT calculations. The nonlinear optical properties were investigated by two‐photon absorption measurements using linearly and circularly polarized light. The extremely twisted structure and packing of the homochiral compound were investigated by single‐crystal X‐ray diffraction analysis. KW - chirality KW - enantiomers KW - helicenes KW - polycyclic aromatic hydrocarbons KW - stereospecific sythesis Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-208682 VL - 25 IS - 71 ER - TY - JOUR A1 - Zahran, Eman Maher A1 - Albohy, Amgad A1 - Khalil, Amira A1 - Ibrahim, Alyaa Hatem A1 - Ahmed, Heba Ali A1 - El-Hossary, Ebaa M. A1 - Bringmann, Gerhard A1 - Abdelmohsen, Usama Ramadan T1 - Bioactivity Potential of Marine Natural Products from Scleractinia-Associated Microbes and In Silico Anti-SARS-COV-2 Evaluation JF - Marine Drugs N2 - Marine organisms and their associated microbes are rich in diverse chemical leads. With the development of marine biotechnology, a considerable number of research activities are focused on marine bacteria and fungi-derived bioactive compounds. Marine bacteria and fungi are ranked on the top of the hierarchy of all organisms, as they are responsible for producing a wide range of bioactive secondary metabolites with possible pharmaceutical applications. Thus, they have the potential to provide future drugs against challenging diseases, such as cancer, a range of viral diseases, malaria, and inflammation. This review aims at describing the literature on secondary metabolites that have been obtained from Scleractinian-associated organisms including bacteria, fungi, and zooxanthellae, with full coverage of the period from 1982 to 2020, as well as illustrating their biological activities and structure activity relationship (SAR). Moreover, all these compounds were filtered based on ADME analysis to determine their physicochemical properties, and 15 compounds were selected. The selected compounds were virtually investigated for potential inhibition for SARS-CoV-2 targets using molecular docking studies. Promising potential results against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and methyltransferase (nsp16) are presented. KW - Scleractinia KW - marine bacteria KW - marine fungi KW - zooxanthellae KW - marine natural products KW - ADME analysis KW - SARS-CoV-2 KW - molecular docking KW - RNA-dependent RNA polymerase KW - methyltransferase Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-220041 SN - 1660-3397 VL - 18 IS - 12 ER - TY - JOUR A1 - Würthner, Frank A1 - Noll, Niklas T1 - A Calix[4]arene‐Based Cyclic Dinuclear Ruthenium Complex for Light‐Driven Catalytic Water Oxidation JF - Chemistry - A European Journal N2 - A cyclic dinuclear ruthenium(bda) (bda: 2,2’‐bipyridine‐6,6’‐dicarboxylate) complex equipped with oligo(ethylene glycol)‐functionalized axial calix[4]arene ligands has been synthesized for homogenous catalytic water oxidation. This novel Ru(bda) macrocycle showed significantly increased catalytic activity in chemical and photocatalytic water oxidation compared to the archetype mononuclear reference [Ru(bda)(pic)\(_2\)]. Kinetic investigations, including kinetic isotope effect studies, disclosed a unimolecular water nucleophilic attack mechanism of this novel dinuclear water oxidation catalyst (WOC) under the involvement of the second coordination sphere. Photocatalytic water oxidation with this cyclic dinuclear Ru complex using [Ru(bpy)\(_3\)]Cl\(_2\) as a standard photosensitizer revealed a turnover frequency of 15.5 s\(^{−1}\) and a turnover number of 460. This so far highest photocatalytic performance reported for a Ru(bda) complex underlines the potential of this water‐soluble WOC for artificial photosynthesis. KW - water KW - oxidation KW - ruthenium KW - dinuclear KW - catalytic KW - artificial photosynthesis KW - homogenous catalysis KW - photocatalysis KW - ruthenium complexes KW - water oxidation Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-230030 UR - https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/chem.202004486 VL - 27 IS - 1 ER - TY - JOUR A1 - Würthner, Frank A1 - Meza-Chincha, Ana-Lucia A1 - Schindler, Dorothee A1 - Natali, Mirco T1 - Effects of Photosensitizers and Reaction Media on Light‐Driven Water Oxidation with Trinuclear Ruthenium Macrocycles JF - ChemPhotoChem N2 - Photocatalytic water oxidation is a promising process for the production of solar fuels and the elucidation of factors that influence this process is of high significance. Thus, we have studied in detail light‐driven water oxidation with a trinuclear Ru(bda) (bda: 2,2’‐bipyridine‐6,6’‐dicarboxylate) macrocycle MC3 and its highly water soluble derivative m‐CH\(_2\)NMe\(_2\)‐MC3 using a series of ruthenium tris(bipyridine) complexes as photosensitizers under varied reaction conditions. Our investigations showed that the catalytic activities of these Ru macrocycles are significantly affected by the choice of photosensitizer (PS) and reaction media, in addition to buffer concentration, light intensity and concentration of the sensitizer. Our steady‐state and transient spectroscopic studies revealed that the photocatalytic performance of trinuclear Ru(bda) macrocycles is not limited by their intrinsic catalytic activities but rather by the efficiency of photogeneration of oxidant PS\(^+\) and its ability to act as an oxidizing agent to the catalysts as both are strongly dependent on the choice of photosensitizer and the amount of employed organic co‐solvent. KW - photosenitizers KW - water oxidation KW - ruthenium complexes KW - macrocycles KW - trinuclear KW - homogenous catalysis KW - photocatalysis Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-230116 VL - 5 IS - 2 ER - TY - JOUR A1 - Wächtler, Maria A1 - Kübel, Joachim A1 - Barthelmes, Kevin A1 - Winter, Andreas A1 - Schmiedel, Alexander A1 - Pascher, Torbjörn A1 - Lambert, Christoph A1 - Schubert, Ulrich S. A1 - Dietzek, Benjamin T1 - Energy transfer and formation of long-lived \(^3\)MLCT states in multimetallic complexes with extended highly conjugated bis-terpyridyl ligands JF - Physical Chemistry Chemical Physics N2 - Multimetallic complexes with extended and highly conjugated bis-2,2':6',2''-terpyridyl bridging ligands, which present building blocks for coordination polymers, are investigated with respect to their ability to act as light-harvesting antennae. The investigated species combine Ru(II)- with Os(II)- and Fe(II)-terpyridyl chromophores, the latter acting as energy sinks. Due to the extended conjugated system the ligands are able to prolong the lifetime of the \(^3\)MLCT states compared to unsubstituted terpyridyl species by delocalization and energetic stabilization of the \(^3\)MLCT states. This concept is applied for the first time to Fe(II) terpyridyl species and results in an exceptionally long lifetime of 23 ps for the Fe(II) \(^3\)MLCT state. While partial energy (>80%) transfer is observed between the Ru(II) and Fe(II) centers with a time-constant of 15 ps, excitation energy is transferred completely from the Ru(II) to the Os(II) center within the first 200 fs after excitation. KW - polypyridyl complexes KW - bis-terpyridyl ligands KW - multimetallic complexes KW - metal-to-ligand charge transfer (MLCT) KW - RU-(II) complexes KW - Ru(II)–Fe(II)–Ru(II) complex Y1 - 2016 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-191041 VL - 18 IS - 4 ER - TY - JOUR A1 - Wu, Zhu A1 - Roldao, Juan Carlos A1 - Rauch, Florian A1 - Friedrich, Alexandra A1 - Ferger, Matthias A1 - Würthner, Frank A1 - Gierschner, Johannes A1 - Marder, Todd B. T1 - Pure Boric Acid Does Not Show Room-Temperature Phosphorescence (RTP) JF - Angewandte Chemie N2 - Boric acid (BA) has been used as a transparent glass matrix for optical materials for over 100 years. However, recently, apparent room-temperature phosphorescence (RTP) from BA (crystalline and powder states) was reported (Zheng et al., Angew. Chem. Int. Ed. 2021, 60, 9500) when irradiated at 280 nm under ambient conditions. We suspected that RTP from their BA sample was induced by an unidentified impurity. Our experimental results show that pure BA synthesized from B(OMe)\(_{3}\) does not luminesce in the solid state when irradiated at 250–400 nm, while commercial BA indeed (faintly) luminesces. Our theoretical calculations show that neither individual BA molecules nor aggregates would absorb light at >175 nm, and we observe no absorption of solid pure BA experimentally at >200 nm. Therefore, it is not possible for pure BA to be excited at >250 nm even in the solid state. Thus, pure BA does not display RTP, whereas trace impurities can induce RTP. KW - boric acid KW - room-temperature phosphorescence (RTP) KW - optical materials Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-318308 VL - 61 IS - 15 ER - TY - JOUR A1 - Wu, Zhu A1 - Dinkelbach, Fabian A1 - Kerner, Florian A1 - Friedrich, Alexandra A1 - Ji, Lei A1 - Stepanenko, Vladimir A1 - Würthner, Frank A1 - Marian, Christel M. A1 - Marder, Todd B. T1 - Aggregation-Induced Dual Phosphorescence from (o-Bromophenyl)-Bis(2,6-Dimethylphenyl)Borane at Room Temperature JF - Chemistry—A European Journal N2 - Designing highly efficient purely organic phosphors at room temperature remains a challenge because of fast non-radiative processes and slow intersystem crossing (ISC) rates. The majority of them emit only single component phosphorescence. Herein, we have prepared 3 isomers (o, m, p-bromophenyl)-bis(2,6-dimethylphenyl)boranes. Among the 3 isomers (o-, m- and p-BrTAB) synthesized, the ortho-one is the only one which shows dual phosphorescence, with a short lifetime of 0.8 ms and a long lifetime of 234 ms in the crystalline state at room temperature. Based on theoretical calculations and crystal structure analysis of o-BrTAB, the short lifetime component is ascribed to the T\(^M_1\) state of the monomer which emits the higher energy phosphorescence. The long-lived, lower energy phosphorescence emission is attributed to the T\(^A_1\) state of an aggregate, with multiple intermolecular interactions existing in crystalline o-BrTAB inhibiting nonradiative decay and stabilizing the triplet states efficiently. KW - AIE KW - luminescence KW - phosphorescence KW - triarylborane KW - triplet Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-318297 VL - 28 IS - 30 ER -